Clinical Trials Browser

CUDC-907 × CNS × 90 days × Clear all

NCT02909777 2026-02-11

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Phase 1 Completed

Brain Neoplasms, Lymphoma, Neuroblastoma